Therapy insight: What nephrologists need to know about primary vesicoureteral reflux.
Vesicoureteral reflux (VUR) is the abnormal, retrograde flow of urine from the bladder to the upper urinary tract. This disease affects about 1% of otherwise normal children, 30-50% of those who present with urinary tract infections, and approximately 10% with prenatally diagnosed hydronephrosis. Over the past 50 years, tremendous progress has been made in the diagnosis, treatment and management of VUR. The realization that VUR is probably a component of generalized dysfunction of the lower urinary tract (i.e. dysfunctional elimination syndrome) has further enhanced understanding of the disease. This Review covers basic pathogenesis, diagnosis, management, clinical presentation, and current controversies surrounding VUR.
Gargollo
Patricio C
PC
Harvard Medical School, and Children's Hospital Boston, Boston, MA 02115, USA.
Diamond
David A
DA
D019072:Antibiotic Prophylaxis; D002921:Cicatrix / Q000517:prevention & control; D004502:Education, Medical, Continuing; D004724:Endoscopy; D006801:Humans; D007674:Kidney Diseases / Q000517:prevention & control; D007676:Kidney Failure, Chronic / Q000209:etiology; D009398:Nephrology / Q000193:education* / Q000379:methods; D010372:Pediatrics / Q000379:methods; D013520:Urologic Surgical Procedures; D014572:Urology / Q000379:methods; D014718:Vesico-Ureteral Reflux / Q000150:complications / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*